1. Articles from Optovue Incorporated

    1-24 of 31 1 2 »
    1. Optovue Introduces NetVue™ Cloud Image Management Solutions at the American Academy of Ophthalmology (AAO) Annual Meeting

      Optovue Introduces NetVue™ Cloud Image Management Solutions at the American Academy of Ophthalmology (AAO) Annual Meeting

      Optovue , the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), will introduce NetVue™ Cloud image management software at AAO 2019 in San Francisco , October 12-15 , 2019. The NetVue software provides quick access to patients' images and data on a single screen, eliminating the need to open device-specific applications. Unlike other solutions on the market, there is no gateway application required, so images can be viewed anytime and from any device directly from any web browser. And cloud-based storage keeps patients' images and data safe and secure. "As medical practices continue to add imaging devices ...

      Read Full Article
      Mentions: Optovue
    2. Joe Garibaldi Appointed Vice President of U.S. Sales at Optovue

      Joe Garibaldi Appointed Vice President of U.S. Sales at Optovue

      Optovue , the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), today announced the promotion of Joe Garibaldi to vice president of U.S. Sales, where he will continue to lead the U.S. sales force for Optovue as well as identify new strategic partnering opportunities to grow the company’s U.S. product portfolio. Garibaldi joined Optovue in 2009 as a territory manager and he has been promoted into multiple leadership positions within the sales organization where he has led sales growth in both the Optometry and Ophthalmology markets. In recent years, Joe expanded ...

      Read Full Article
      Mentions: Optovue Jay Wei
    3. Optovue Showcases World’s First OCT Angiography Metrics and Non-contact Method for Corneal Measurements at Vision Expo West

      Optovue Showcases World’s First OCT Angiography Metrics and Non-contact Method for Corneal Measurements at Vision Expo West

      Company Introduces Non-mydriatic Ophthalmic Camera Optovue, the global leader in the development of optical coherence tomography ( OCT ) and OCT angiography ( OCTA ), will showcase AngioAnalytics™, the world’s first OCTA blood vessel measurement technology to help clinicians manage diseases that cause progressive blindness, and 3D PAR, its three-dimensional projection artifact removal software at Vision Expo West 2018. The company will also highlight its 9mm Epithelial Thickness Mapping (ETM), a wider version of its non-contact, quantitative method for corneal epithelia and stromal measurements, and debut its new non-mydriatic ophthalmic camera, Vivicon, offering a touch-screen tablet interface with fully automatic alignment and image ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA
    4. Optovue Announces Expanded FDA Clearance of Epithelial Thickness Mapping

      Optovue Announces Expanded FDA Clearance of Epithelial Thickness Mapping

      Optovue , the global leader in the development of optical coherence tomography ( OCT ) and OCT angiography ( OCTA ), today announced an expanded FDA 510(k) clearance for non-contact, quantitative measurements of the epithelial and stromal layers of the cornea, termed epithelial thickness mapping or ETM. The expanded clearance adds a nine-millimeter ETM scan to the previously available six-millimeter map, allowing for detection of epithelial irregularities in an area that is about two-and-a-quarter times that of the area covered by the six-millimeter scan. Optovue’s ETM, now available on the Avanti® Widefield OCT system, is the first and only FDA-cleared product indicated to ...

      Read Full Article
    5. Optovue Receives FDA Clearance for AngioAnalytics – the World’s First OCT Angiography Metrics

      Optovue Receives FDA Clearance for AngioAnalytics – the World’s First OCT Angiography Metrics

      Optovue announced FDA 510(k) clearance of AngioAnalytics™, the world’s first optical coherence tomography angiography (OCTA) blood vessel measurement technology to help clinicians manage diseases that cause progressive blindness. The company also received clearance for its three-dimensional projection artifact removal (3D PAR) software, which greatly improves OCTA image quality and enables accurate measurement and interpretation of OCTA images. AngioAnalytics and 3D PAR are commercially available in the U.S. “AngioAnalytics and 3D PAR are game changers because they 'erase' overlying inner retinal blood vessel artifacts allowing for better visualization and more accurate measurement of the outer retina and choroidal ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA
    6. Optovue Announces Retirement of Prominent Industry Veteran John Hawley

      Optovue Announces Retirement of Prominent Industry Veteran John Hawley

      - Optovue the global leader in the development of optical coherence tomography ( OCT ) and OCT angiography ( OCTA ), today announced the retirement of renowned industry veteran John Hawley, the company’s senior vice president of global sales. Hawley will retire on July 1, 2018 and remain with Optovue in an advisory role. Prominent industry veteran John Hawley retires from Optovue. Tweet this “For the past 10 years, I have worked side-by-side with John as we built Optovue from a fledgling start-up to the global company we are today,” said Jay Wei, founder and chief executive officer of Optovue. “As a result of ...

      Read Full Article
      Mentions: Optovue Jay Wei
    7. Optovue Unveils New AngioVue Essential OCTA at the International Vision Expo

      Optovue Unveils New AngioVue Essential OCTA at the International Vision Expo

      Optovue , the global leader in the development of optical coherence tomography ( OCT ) and OCT angiography ( OCTA ), will debut its AngioVue® Essential OCTA capability for optometry and general ophthalmology at the upcoming International Vision Expo & Conference 2017 in Las Vegas. AngioVue Essential aids clinicians’ ability to visualize ocular disease by providing high-resolution, non-invasive imaging of retinal vasculature. Optimized for optometry and general ophthalmology practices, AngioVue Essential provides fundamental OCTA features in a single-page report that displays individual layers of retinal vasculature alongside structural OCT B-scans. As a result, clinicians can quickly transform a basic eye exam into a comprehensive assessment of ...

      Read Full Article
      Mentions: Optovue
    8. Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping New Mapping Technique May be Early Indicator of Ocular Health

      Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping New Mapping Technique May be Early Indicator of Ocular Health

      Optovue announced today that the U.S. Food and Drug Administration (FDA) has cleared the company’s epithelial thickness mapping software (epi-mapping) for quantitative measurements of the epithelial and stromal layers of the cornea. Epi-mapping is the first non-contact, quantitative method for corneal epithelia and stromal measurements, and it is the first and only FDA-cleared product indicated to provide corneal epithelia and stromal measurements that aid in the diagnosis, documentation and management of ocular health and diseases in the adult population. “The measurement of corneal epithelial thickness is becoming more recognized as a vital part of assessing patients for refractive ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA
    9. Optovue Launches Vault Mapping at Vision Expo West for Scleral Contact Lens Fitting

      Optovue Launches Vault Mapping at Vision Expo West for Scleral Contact Lens Fitting

      Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), introduced Vault Mapping for all iSeries OCT systems this week at the International Vision Expo West , Sept. 15-17. The new Vault Mapping software can be used to assist in scleral lens fitting by allowing visualization and mapping of the central corneal clearance (CCC), a key measurement related to how well the lens rests on the eye. Optovue also introduced its proprietary AngioVue™ Imaging System to the optometry market and announced two in-booth presentations -- one on Vault Mapping by Jeffrey Sonsino, OD, and one on ...

      Read Full Article
      Mentions: Optovue
    10. Optovue Announces DualTrac Motion Correction Technology for Faster, Improved Imaging

      Optovue Announces DualTrac Motion Correction Technology for Faster, Improved Imaging

      Company to Host Educational Symposium on OCT Angiography Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), today announced the availability of DualTrac™ Motion Correction technology on the AngioVue™ Imaging System at the 34th Annual Scientific meeting of the American Society of Retina Specialists (ASRS) in San Francisco (Booth #801). DualTrac Motion Correction is a two-level approach to correcting motion artifact on patients who have difficulty focusing on a central visual point during an eye exam, which is essential for high-quality OCTA imaging. According to David Sarraf, M.D., Clinical Professor of Ophthalmology ...

      Read Full Article
    11. Optovue Announces New Distribution Agreement With ROCOL in Colombia

      Optovue Announces New Distribution Agreement With ROCOL in Colombia

      Optovue, the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced a partnership with ROCOL SA, a medical equipment distributor in Colombia. ROCOL focuses on providing the highest quality products in the areas of ophthalmology, oncology, aesthetics and surgery. "Optovue is extremely proud to be partnering with one of the premier leaders in the marketing and distribution of ophthalmology products in Colombia," said John Hawley, senior vice president, global sales for Optovue. "ROCOL has superb relationships with doctors, a strong understanding of patient care, and a successful track record of representing high-end, leading technologies ...

      Read Full Article
      Mentions: Optovue
    12. OPTOVUE ANNOUNCES NEW ANGIOVUE RETINA IMAGING SYSTEM COMMERCIAL AVAILABILITY

      OPTOVUE ANNOUNCES NEW ANGIOVUE RETINA IMAGING SYSTEM COMMERCIAL AVAILABILITY

      Optovue, the global leader in the development of optical coherence tomography ( OCT ) and OCT angiography ( OCTA ), today announced immediate availability of AngioVue™ Retina , a proprietary imaging system that provides retina specialists with a non-invasive, dyeless way to quickly visualize blood flow in the retina, the light sensitive portion in the back of the eye. AngioVue Retina is configured with essential OCTA and OCT features designed specifically for retinal practices to allow adoption of OCT and OCTA into the clinical workflow with minimal disruption. “By adding AngioVue Retina to our product portfolio, we are able to help retinal physicians acquire OCTA ...

      Read Full Article
      Mentions: Optovue FDA
    13. Optovue’s AngioVue Imaging System Receives FDA Clearance

      Optovue’s AngioVue Imaging System Receives FDA Clearance

      Optovue, the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced FDA clearance and immediate U.S. commercial availability of the AngioVue™** Imaging System, a groundbreaking technology that provides a non-invasive way to visualize abnormal blood vessels to help physicians determine an appropriate course of treatment. “We are thrilled to announce FDA clearance of our AngioVue System, which will bring the significant benefits of our innovative, non-invasive retinal imaging to patients in the U.S. who suffer from retinal diseases that lead to progressive blindness,” said Jay Wei, founder and chief executive officer at ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA
    14. Optovue Releases AngioAnalytics, World's First OCTA Blood Vessel Measurement Technology

      Optovue Releases AngioAnalytics, World's First OCTA Blood Vessel Measurement Technology

      Optovue , the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced commercial availability of AngioAnalytics™*, the next generation of its OCTA technology available on the AngioVue™ ** Imaging System, for use outside of the U.S. This new capability enables clinicians to quantify the density of blood flow in the retina, the light-sensitive portion of the eye, to help manage diseases that cause progressive blindness such as diabetic retinopathy or acute macular degeneration. Optovue also announced it will host an educational symposium at the World Ophthalmology Congress ( WOC 2016 ) entitled, "The Transformative Power of Quantitative ...

      Read Full Article
    15. Systems Software Engineer at Optovue (Advanced Development)

      Systems Software Engineer at Optovue (Advanced Development)

      About Us: Optovue, Inc. (Fremont, CA) is an ophthalmic device company dedicated to working with eye care professionals, doctors and researchers to improve patient care through sustained technological innovation. The Advanced Development Team at Optovue is primarily responsible for identifying, evaluating and developing cutting-edge technologies in the field of ophthalmic and optical imaging. Innovation is firmly entrenched in our DNA and we take pride in the fact that Optovue has pioneered breakthrough medical imaging technologies including spectral-domain OCT and OCT Angiography that have been revolutionizing the field of ophthalmology. We remain passionate about generating, prototyping and evaluating new concepts and ...

      Read Full Article
      Mentions: Optovue
    16. OCT Imaging Scientist Position at Optovue

      OCT Imaging Scientist Position at Optovue

      About Us: Optovue, Inc. (Fremont, CA) is an ophthalmic device company dedicated to working with eye care professionals, doctors and researchers to improve patient care through sustained technological innovation. The Advanced Development Team at Optovue is primarily responsible for identifying, evaluating and developing cutting-edge technologies in the field of ophthalmic and optical imaging. Innovation is firmly entrenched in our DNA and we take pride in the fact that Optovue has pioneered breakthrough medical imaging technologies including spectral-domain OCT and OCT Angiography that have been revolutionizing the field of ophthalmology. We remain passionate about generating, prototyping and evaluating new concepts and ...

      Read Full Article
      Mentions: Optovue
    17. Optical Imaging Scientist Position at Optovue

      Optical Imaging Scientist Position at Optovue

      About Us: Optovue, Inc. (Fremont, CA) is an ophthalmic device company dedicated to working with eye care professionals, doctors and researchers to improve patient care through sustained technological innovation. The Advanced Development Team at Optovue is primarily responsible for identifying, evaluating and developing cutting-edge technologies in the field of ophthalmic and optical imaging. Innovation is firmly entrenched in our DNA and we take pride in the fact that Optovue has pioneered disruptive medical imaging technologies including spectral-domain OCT and OCT Angiography that have been revolutionizing the field of ophthalmology. We remain passionate about generating, prototyping and evaluating new concepts and ...

      Read Full Article
      Mentions: Optovue
    18. Staff/Senior Research Scientist (Advanced Algorithms) at Optovue

      Staff/Senior Research Scientist (Advanced Algorithms) at Optovue

      About Us: Optovue, Inc. (Fremont, CA) is an ophthalmic device company dedicated to working with eye care professionals, doctors and researchers to improve patient care through sustained technological innovation. The Advanced Algorithms Team at Optovue is primarily responsible for identifying and developing cutting-edge applications in the field of ophthalmic and optical imaging. Innovation is firmly entrenched in our DNA and we take pride in the fact that Optovue has pioneered disruptive medical imaging technologies including spectral-domain OCT and OCT Angiography that have been revolutionizing the field of ophthalmology. We remain passionate about generating, prototyping and evaluating new concepts and ideas ...

      Read Full Article
      Mentions: Optovue FDA
    19. Optovue Announces USD30 Million Private Equity Investment Agreement with Delta to Fuel Continued Innovation

      Optovue Announces USD30 Million Private Equity Investment Agreement with Delta to Fuel Continued Innovation

      Optovue, Inc., a global leader in the development and commercialization of optical coherence tomography (OCT) and OCT angiography technology for the eye care market, today announced it has executed an agreement to receive USD30 million in private equity funding from Deltronics (Netherlands) B.V., a subsidiary of Delta Electronics, Inc., a global leader in power and thermal management solutions. The funding will enable Optovue to expand its current imaging platforms, and to further the commercialization and development of applications for the AngioVue™* Imaging System, its newest innovation that embodies OCT angiography. This long-term investment also allows Delta to extend its ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA
    20. Senior Scientist Opening at Optovue

      Senior Scientist Opening at Optovue

      About Us: Optovue, Inc. (Fremont, CA) is an ophthalmic device company dedicated to working with eye care professionals, doctors and researchers to improve patient care through sustained technological innovation. The Advanced Development Team at Optovue is primarily responsible for identifying, evaluating and developing cutting-edge technologies in the field of ophthalmic and optical imaging. Innovation is firmly entrenched in our DNA and we take pride in the fact that Optovue has pioneered disruptive medical imaging technologies including spectral-domain OCT and OCT Angiography that have been revolutionizing the field of ophthalmology. We remain passionate about generating, prototyping and evaluating new concepts and ...

      Read Full Article
      Mentions: Optovue
    21. Optovue Showcases Retinal Blood Flow Measurement Capability for Improving Management of Diabetes-Related Vision Loss

      Optovue Showcases Retinal Blood Flow Measurement Capability for Improving Management of Diabetes-Related Vision Loss

      AngioAnalytics, World’s First OCT Angiography Quantification Technology, Announced at Prestigious European Society for Cataract and Refractive Surgery Optovue, the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced AngioAnalytics™, a significant expansion of its OCTA technology, at the 33rd congress of the European Society for Cataract and Refractive Surgery (ESCRS) being held in Barcelona, Spain from September 5-9. This new capability will provide clinicians with the ability to quantify the density of blood flow in the retina, the light-sensitive portion of the eye. “For the first time ever, ophthalmologists will have the ability ...

      Read Full Article
    22. Optovue Introduces Two New Configurations of Software-Assisted OCT Device

      Optovue Introduces Two New Configurations of Software-Assisted OCT Device

      Optovue, a pioneer in spectral-domain optical coherence tomography (SD-OCT), announced that it has launched two new configurations of its iScan TM software-assisted OCT system: iScan Essential and iScan Comprehensive. The two product configurations are intended to give practitioners a choice in how they bring OCT technology into their practices. Both iScan Essential and iScan Comprehensive were created to simplify OCT technology, thus making it accessible to a range of eye care professionals in any practice setting. iScan's software-assisted platform vocally guides the patient through the entire exam and requires minimal operator involvement. The system's compact footprint and tabletop ...

      Read Full Article
      Mentions: Optovue OptiScan
    23. Optovue Launches Next Generation Widefield Enface OCT

      Optovue Launches Next Generation Widefield Enface OCT

      Optovue ( www.optovue.com ), a pioneer in spectral-domain optical coherence tomography (SD-OCT), today announced the worldwide launch and availability of Avanti Widefield Enface OCT. Avanti will make its US debut at the annual American Academy of Ophthalmology (AAO) meeting, November 16-19 in New Orleans. Avanti is a next generation diagnostic device providing an all-in-one solution for posterior and anterior high-speed, high-resolution OCT imaging offering 70,000 A-scans per second, Widefield 3D motion correction and 3 micron digital resolution (sampling). With the next wave of OCT technology innovation in mind, Avanti is designed as a scalable platform to take eye care ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA
    1-24 of 31 1 2 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics in the News

    1. (31 articles) Optovue
    2. (15 articles) FDA
    3. (14 articles) Jay Wei
    4. (8 articles) Optovue iVue
    5. (6 articles) Optovue RTVue-100
    6. (4 articles) Paul Kealey
    7. (3 articles) New York Eye and Ear Infirmary
    8. (3 articles) Richard B. Rosen
    9. (2 articles) World Health Organization
    10. (2 articles) David Huang
    11. (1 articles) University of Pittsburgh
    12. (1 articles) ESPCI ParisTech
    13. (1 articles) University of Toronto
    14. (1 articles) Felix I. Feldchtein
    15. (1 articles) Mathias Fink
    16. (1 articles) Claude Boccara
    17. (1 articles) I. Alex Vitkin
    18. (1 articles) Egidijus Auksorius
    19. (1 articles) Kate Grieve
    20. (1 articles) Maciej Wojtkowski
  3. Popular Articles

  4. Picture Gallery

    Optovue Showcases Retinal Blood Flow Measurement Capability for Improving Management of Diabetes-Related Vision Loss Senior Scientist Opening at Optovue Optovue Announces USD30 Million Private Equity Investment Agreement with Delta to Fuel Continued Innovation Staff/Senior Research Scientist (Advanced Algorithms) at Optovue Optical Imaging Scientist Position at Optovue OCT Imaging Scientist Position at Optovue Systems Software Engineer at Optovue (Advanced Development) Optovue Releases AngioAnalytics, World's First OCTA Blood Vessel Measurement Technology Optovue’s AngioVue Imaging System Receives FDA Clearance Optovue Announces DualTrac Motion Correction Technology for Faster, Improved Imaging Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment Optical coherence angiography for pre-treatment assessment and treatment monitoring following photodynamic therapy: a basal cell carcinoma patient study